T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.62B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$1.61B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Lam Research
LRCX
|
+$1.17B |
| 5 |
Las Vegas Sands
LVS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$1.4B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Tesla
TSLA
|
+$1.13B |
| 4 |
JPMorgan Chase
JPM
|
+$1.11B |
| 5 |
Morgan Stanley
MS
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 15.3% |
| 4 | Consumer Discretionary | 15.25% |
| 5 | Communication Services | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTSV
1326
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $11.2M | ﹤0.01% |
+702,000
| New | +$10.9M |
|
|
FL
1327
DELISTED
Foot Locker
FL
| $11.1M | ﹤0.01% |
211,478
-160
| -0.1% | -$7.74K |
|
1328
Fluor
FLR
$7.09B
| $11.1M | ﹤0.01% |
227,304
| – | – |
|
1329
Synaptics
SYNA
$4.23B
| $10.8M | ﹤0.01% |
214,725
+4,041
| +2% | +$183K |
|
1330
AngioDynamics
ANGO
$645M
| $10.7M | ﹤0.01% |
482,296
+8,440
| +2% | +$173K |
|
|
NTUS
1331
DELISTED
Natus Medical Inc
NTUS
| $10.6M | ﹤0.01% |
308,349
+39,340
| +15% | +$1.38M |
|
|
GRMN
1332
Garmin
GRMN
$59.7B
| $10.6M | ﹤0.01% |
172,979
+1,700
| +1% | +$102K |
|
1333
Spotify
SPOT
$105B
| $10.5M | ﹤0.01% |
+62,374
| New | +$9.97M |
|
|
MRTX
1334
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $10.5M | ﹤0.01% |
212,465
+26,145
| +14% | +$987K |
|
|
NFX
1335
DELISTED
Newfield Exploration
NFX
| $10.3M | ﹤0.01% |
340,993
+340
| +0.1% | +$9.61K |
|
|
TRHC
1336
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $10.2M | ﹤0.01% |
+159,385
| New | +$7.82M |
|
|
JWN
1337
DELISTED
Nordstrom
JWN
| $10.2M | ﹤0.01% |
196,405
+467
| +0.2% | +$23.2K |
|
|
DPLO
1338
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $10.1M | ﹤0.01% |
394,882
+225,569
| +133% | +$5.26M |
|
1339
Saia
SAIA
$10.2B
| $10.1M | ﹤0.01% |
124,334
-180,337
| -59% | -$13.9M |
|
1340
Rigel Pharmaceuticals
RIGL
$783M
| $10M | ﹤0.01% |
354,085
+85,509
| +32% | +$3.04M |
|
1341
Ichor Holdings
ICHR
$2.64B
| $10M | ﹤0.01% |
471,599
-407,063
| -46% | -$9.72M |
|
1342
Aaon
AAON
$7.26B
| $9.98M | ﹤0.01% |
450,422
-328,560
| -42% | -$7.22M |
|
|
CLDR
1343
DELISTED
Cloudera, Inc.
CLDR
| $9.96M | ﹤0.01% |
+730,466
| New | +$11.1M |
|
1344
Leggett & Platt
LEG
$1.32B
| $9.94M | ﹤0.01% |
222,666
| – | – |
|
|
AXON
1345
Axon Enterprise
AXON
$49.9B
| $9.77M | ﹤0.01% |
154,618
-6,834
| -4% | -$370K |
|
1346
Telecom Argentina
TEO
$5.73B
| $9.65M | ﹤0.01% |
543,725
+137,780
| +34% | +$3.5M |
|
|
PBCT
1347
DELISTED
People's United Financial Inc
PBCT
| $9.61M | ﹤0.01% |
531,231
-97,400
| -15% | -$1.81M |
|
1348
Goodyear
GT
$1.75B
| $9.6M | ﹤0.01% |
412,194
+10,600
| +3% | +$272K |
|
1349
Quanta Services
PWR
$104B
| $9.45M | ﹤0.01% |
282,780
| – | – |
|
|
ACOR
1350
DELISTED
Acorda Therapeutics
ACOR
| $9.4M | ﹤0.01% |
2,729
+704
| +35% | +$2.16M |
|
Similar funds
T. Rowe Price Associates's Q2 2018 Portfolio in Review
As of Q2 2018, T. Rowe Price Associates held 2,648 positions worth $654B, up 4% from $629B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2018 filing shows 98 new, 1,625 increased, 741 reduced and 68 closed positions. Its largest new stake was Evergy: 16,595,898 shares worth $932M. The largest sale was Yum! Brands, an estimated $1.4B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2018 buy was Evergy: 16,595,898 shares worth $932M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.62B increase.
- T. Rowe Price Associates's biggest Q2 2018 reduction was Yum! Brands, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $912M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $654B portfolio in Q2 2018.
- T. Rowe Price Associates opened 98 new positions and closed 68 in Q2 2018.
- T. Rowe Price Associates's portfolio value rose 4% quarter-over-quarter to $654B.
Based on T. Rowe Price Associates's 13F filing for Q2 2018, filed 14 Aug 2018.